Avalo Therapeutics Inc (AVTX)

Currency in USD
18.320
-0.380(-2.03%)
Closed·
18.390+0.070(+0.38%)
·
AVTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.90019.050
52 wk Range
8.29024.270
Key Statistics
Prev. Close
18.7
Open
18.87
Day's Range
17.9-19.05
52 wk Range
8.29-24.27
Volume
730.25K
Average Volume (3m)
1.51M
1-Year Change
105.1512%
Book Value / Share
8.54
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44.154
Upside
+141.01%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

Avalo Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

15 Buy
0 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 44.154
(+141.01% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy48.00+162.01%50.00Maintain06-08-2026
Cantor Fitzgerald
Buy---Maintain24-07-2026
Leerink
Buy38.00+107.42%-New Coverage06-07-2026
BofA Securities
Buy35.00+91.05%-New Coverage12-06-2026
H.C. Wainwright
Buy35.00+91.05%40.00Maintain14-05-2026

Earnings

Latest Release
06-08-2026
EPS / Forecast
-0.83 / -0.58
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AVTX Income Statement

Compare AVTX to Peers and Sector

Metrics to compare
AVTX
Peers
Sector
Relationship
P/E Ratio
−9.8x−3.6x−0.4x
PEG Ratio
−0.21−0.040.00
Price/Book
2.2x2.2x2.6x
Price / LTM Sales
16,652.6x69.4x3.1x
Upside (Analyst Target)
129.3%252.6%48.8%
Fair Value Upside
Unlock3.8%5.7%Unlock

Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
11.44M21.62%209.51M
Other Institutional Investors
50.93M78.38%933.02M
Public Companies & Retail Investors
0.000.00%0.00
Total
62.37M100.00%1.14B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC9.64%51,00,21693,436
BlackRock, Inc.6.46%34,15,73162,576

FAQ

What Is the Avalo Therapeutics (AVTX) Share Price Today?

The Avalo Therapeutics share price today is 18.320.

What is the current Avalo Therapeutics (AVTX) share price and day range?

As of 09-08-2026, the Avalo Therapeutics share price is 18.320, with a previous close of 18.700. The share price has ranged from 17.900 to 19.050 today, while the 52-week range spans from 8.290 to 24.270.

What Is the Avalo Therapeutics Market Cap?

As of today, Avalo Therapeutics market cap is 982.500M.

What Is the Avalo Therapeutics (AVTX) Share Price Target?

The average 12-month share price target for Avalo Therapeutics is 44.154, with a high estimate of 60 and a low estimate of 30. 15 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +141.01% Upside potential.

What Is Avalo Therapeutics's Earnings Per Share (TTM)?

The Avalo Therapeutics EPS (TTM) is -4.177.

When Is the Next Avalo Therapeutics Earnings Date?

Avalo Therapeutics will release its next earnings report on 05-11-2026.

From a Technical Analysis Perspective, Is AVTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What Stock Exchange Does Avalo Therapeutics Trade On?

Avalo Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Avalo Therapeutics?

The stock symbol for Avalo Therapeutics is "AVTX."

How Many Times Has Avalo Therapeutics Stock Split?

Avalo Therapeutics has split 2 times.

How Many Employees Does Avalo Therapeutics Have?

Avalo Therapeutics has 33 employees.

What Is the AVTX Premarket Price?

AVTX's last pre-market stock price is 18.300. The pre-market share volume is 3,210.000, and the stock has changed by -0.400, or -2.140%.

What Is the AVTX After Hours Price?

AVTX's last after hours stock price is 18.390, the stock has changed by 0.070, or 0.380%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.